Jyong Biotech Ltd.
MENS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001954488
No open-market purchases or sales by Jyong Biotech Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.01M in total; no superinvestor holds it.
Holders of 5% or more of MENS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Jyong Biotech Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Perfect Mind Co., Ltd | 13D | 33.34%25.3M shares | New | Apr 24, 20261 filing | Apr 24, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Jyong Biotech Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 24, 20263:06 PM ET | Perfect Mind Co., Ltdand 3 others | 13D | 33.34%25.3M shares | New | Jun 16, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Jyong Biotech Ltd. shares.
No Form 144 notices for Jyong Biotech Ltd. are on file.